Skip to main content
. 2018 May 13;97(9):1671–1682. doi: 10.1007/s00277-018-3361-2

Fig. 1.

Fig. 1

PFS curve for all patients from the initiation of second line treatment (median 19.2 months) and 12-month PFS rate (67.6%)